These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 18996694)
1. Synthesis and biological evaluation of homopiperazine derivatives with beta-aminoacyl group as dipeptidyl peptidase IV inhibitors. Ahn JH; Park WS; Jun MA; Shin MS; Kang SK; Kim KY; Rhee SD; Bae MA; Kim KR; Kim SG; Kim SY; Sohn SK; Kang NS; Lee JO; Lee DH; Cheon HG; Kim SS Bioorg Med Chem Lett; 2008 Dec; 18(24):6525-9. PubMed ID: 18996694 [TBL] [Abstract][Full Text] [Related]
2. Discovery of β-aminoacyl containing thiazolidine derivatives as potent and selective dipeptidyl peptidase IV inhibitors. Park WS; Kang SK; Jun MA; Shin MS; Kim KY; Rhee SD; Bae MA; Kim MS; Kim KR; Kang NS; Yoo SE; Lee JO; Song DH; Silinski P; Schneider SE; Ahn JH; Kim SS Bioorg Med Chem Lett; 2011 Mar; 21(5):1366-70. PubMed ID: 21306895 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, Biological Evaluation, and QPLD Studies of Piperazine Derivatives as Potential DPP-IV Inhibitors. Khalaf RA; Jarad HA; Al-Qirim T; Sabbah D Med Chem; 2021; 17(9):937-944. PubMed ID: 32940185 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and structural determination of beta-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors. Ahn JH; Shin MS; Jun MA; Jung SH; Kang SK; Kim KR; Rhee SD; Kang NS; Kim SY; Sohn SK; Kim SG; Jin MS; Lee JO; Cheon HG; Kim SS Bioorg Med Chem Lett; 2007 May; 17(9):2622-8. PubMed ID: 17331715 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of pyrazoline analogues with beta-amino acyl group as dipeptidyl peptidase IV inhibitors. Jun MA; Park WS; Kang SK; Kim KY; Kim KR; Rhee SD; Bae MA; Kang NS; Sohn SK; Kim SG; Lee JO; Lee DH; Cheon HG; Kim SS; Ahn JH Eur J Med Chem; 2008 Sep; 43(9):1889-902. PubMed ID: 18243422 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors. Liu Y; Si M; Tang L; Shangguan S; Wu H; Li J; Wu P; Ma X; Liu T; Hu Y Bioorg Med Chem; 2013 Sep; 21(18):5679-87. PubMed ID: 23938053 [TBL] [Abstract][Full Text] [Related]
8. Discovery of DA-1229: a potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes. Kim HJ; Kwak WY; Min JP; Lee JY; Yoon TH; Kim HD; Shin CY; Kim MK; Choi SH; Kim HS; Yang EK; Cheong YH; Chae YN; Park KJ; Jang JM; Choi SJ; Son MH; Kim SH; Yoo M; Lee BJ Bioorg Med Chem Lett; 2011 Jun; 21(12):3809-12. PubMed ID: 21570283 [TBL] [Abstract][Full Text] [Related]
9. Discovery of C-(1-aryl-cyclohexyl)-methylamines as selective, orally available inhibitors of dipeptidyl peptidase IV. Namoto K; Sirockin F; Ostermann N; Gessier F; Flohr S; Sedrani R; Gerhartz B; Trappe J; Hassiepen U; Duttaroy A; Ferreira S; Sutton JM; Clark DE; Fenton G; Beswick M; Baeschlin DK Bioorg Med Chem Lett; 2014 Feb; 24(3):731-6. PubMed ID: 24439847 [TBL] [Abstract][Full Text] [Related]
10. [(S)-gamma-(4-Aryl-1-piperazinyl)-l-prolyl]thiazolidines as a novel series of highly potent and long-lasting DPP-IV inhibitors. Yoshida T; Sakashita H; Akahoshi F; Hayashi Y Bioorg Med Chem Lett; 2007 May; 17(9):2618-21. PubMed ID: 17317162 [TBL] [Abstract][Full Text] [Related]
11. [Design, synthesis and in vitro activity of glycinamide-bearing compounds as DPP-IV inhibitors]. Han B; Huan Y; Lin ZY; Li P; Shen ZF; Yin DL; Huang HH Yao Xue Xue Bao; 2010 Nov; 45(11):1379-84. PubMed ID: 21361038 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of thiouracil derivatives as dipeptidyl peptidase IV inhibitors. Sharma M; Singh D; Gupta M Chem Biol Drug Des; 2013 Feb; 81(2):257-64. PubMed ID: 23039850 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of glycolamide, glycinamide, and β-amino carbonyl 1,2,4-triazole derivatives as DPP-4 inhibitors. Fuh MT; Tseng CC; Li SM; Tsai SE; Chuang TJ; Lu CH; Yang YC; Tsai HJ; Wong FF Bioorg Chem; 2021 Sep; 114():105049. PubMed ID: 34147879 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and pharmacological evaluation of highly potent and selective dipeptidyl peptidase-4 inhibitors. Jiang T; Zhou Y; Zhu J; Chen Z; Sun P; Zhang Q; Wang Z; Shao Q; Jiang X; Li B; Wang H; Zhu W; Shen J Arch Pharm (Weinheim); 2015 Jun; 348(6):399-407. PubMed ID: 25871012 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological assay in vitro and molecular docking studies of new imidazopyrazinone derivatives as potential dipeptidyl peptidase IV inhibitors. Zhu Y; Xia S; Zhu M; Yi W; Cheng J; Song G; Li Z; Lu P Eur J Med Chem; 2010 Nov; 45(11):4953-62. PubMed ID: 20800322 [TBL] [Abstract][Full Text] [Related]
16. Discovery of beta-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV. Nordhoff S; Cerezo-Gálvez S; Deppe H; Hill O; López-Canet M; Rummey C; Thiemann M; Matassa VG; Edwards PJ; Feurer A Bioorg Med Chem Lett; 2009 Aug; 19(15):4201-3. PubMed ID: 19515557 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel aminomethyl-piperidones based DPP-IV inhibitors. Jadav P; Bahekar R; Shah SR; Patel D; Joharapurkar A; Jain M; Sairam KV; Singh PK Bioorg Med Chem Lett; 2014 Apr; 24(8):1918-22. PubMed ID: 24675378 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors. Sharma M; Gupta M; Singh D; Kumar M; Kaur P Chem Biol Drug Des; 2012 Dec; 80(6):918-28. PubMed ID: 22943413 [TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis and Biological Evaluation of Spiro Cyclohexane-1,2- Quinazoline Derivatives as Potent Dipeptidyl Peptidase IV Inhibitors. Syam YM; El-Karim SSA; Nasr T; Elseginy SA; Anwar MM; Kamel MM; Ali HF Mini Rev Med Chem; 2019; 19(3):250-269. PubMed ID: 28847268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]